Approval Expanded for Breast Cancer Drug Tykerb
2/1/2010
HealthDay - MONDAY, Feb. 1 (HealthDay News) -- The U.S. Food and Drug
Administration has expanded countenance for Tykerb (lapatini
to include
postmenopausal women with hormone- and HER2-positive forward breast
cancer who require hormone therapy.
More: - Read the rest here
Share and enjoy
Post Comment
Entry 1 of 16100
Last Page | Next Page